NEJM Journal Watch reviews over 250 scientific and medical journals to present important clinical research findings and insightful commentary
Atrial fibrillation (AF) often occurs in patients who are hospitalized for other causes, and it tends to resolve after underlying stressors (e.g.,
Sickle cell disease predisposes patients to hypercoagulability, and pulmonary microthrombosis can contribute to acute chest syndrome even if no
In early trials, camizestrant, a next-generation selective estrogen receptor degrader (SERD) and complete ER antagonist, demonstrated activity in
For patients who undergo percutaneous coronary intervention (PCI) for coronary artery disease, the choice of antiplatelet agent for secondary
Topiramate and zonisamide, originally developed as antiseizure medications, are prescribed increasingly by generalists for other uses such as obesity
NEJM Group’s Dr. André Sofair checks in with the two endocrinologists who will guide our ADA meeting coverage this year: Dr. Nadine Palermo and Dr.…
For patients with resectable gastric cancer, perioperative chemotherapy with fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) is the
Accurate diagnosis of amyotrophic lateral sclerosis (ALS), a relentlessly progressive neurodegenerative disease, can be challenging owing to
Euglycemic diabetic ketoacidosis (DKA) is relatively uncommon, but its incidence seems to be increasing. Sodium–glucose cotransporter-2 (SGLT-2)
Numerous novel anti-estrogens are in development with activity against tumors that express ESR1 mutations, which occur under pressure of treatment and
